IGFBP3 and pancreatic neuroendocrine neoplasm: High expression of IGFBP3 (insulin‐like growth factor binding protein 3) has been associated with lymph node and liver metastasis, and poor outcome in CRC [35, 36] and pancreatic endocrine neoplasms [37].